Method of systemically delivering SSRIs

Details for Australian Patent Application No. 2002357352 (hide)

Owner Duramed Pharmaceuticals, Inc.

Inventors Glazer, Brian; Kay, Martha francine; Zhang, Junxiong; Mahashabde, Anu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002357352

PCT Number PCT/US02/40808

PCT Pub. Number WO2003/055424

Priority 10/095,558 12.03.02 US; 60/343,254 21.12.01 US

Filing date 20 December 2002

Wipo publication date 15 July 2003

Acceptance publication date 6 September 2007

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/02 (2006.01) Medicinal preparations characterised by special physical form - Suppositories

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/4525 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/30 (2006.01) Drugs for disorders of the nervous system

A61F 2/00 (2006.01) Filters

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 10/095,558 12.03.02 US; 60/343,254 21.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002357352

6 September 2007 Application Accepted

  Published as AU-B-2002357352

10 January 2008 Standard Patent Sealed

22 April 2010 Alteration of Name

  The name of the patentee has been altered to Teva Women's Health, Inc. 2003

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357353-MAXIMUM LIFETIME ROUTING IN WIRELESS AD-HOC NETWORKS

2002357351-IMPLANTABLE MEDICAL DEVICE AND METHOD FOR MANUFACTURING THE SAME